Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.7 EUR | -0.75% |
|
+0.12% | +42.03% |
26/06 | Rovi receives non-binding offers for manufacturing business | RE |
08/05 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.03% | 4.8B | |
+55.55% | 816B | |
+40.11% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+14.00% | 238B | |
+1.39% | 222B | |
+13.49% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- Transcript : Laboratorios Farmaceuticos Rovi, S.A., H1 2021 Earnings Call, Jul 28, 2021